Volume 88, Issue 3 , Pages 292-298, March 2005
Serum tumor necrosis factor alpha receptors p55/p75 ratio and ovarian cancer detection
Abstract
Objective
Early ovarian cancer detection is still very difficult and patients are mostly in advanced stages, with obvious influence on poor prognosis.
Method
Fifty-one ovarian cancer patients and 16 healthy controls had the serum concentrations of TNFα receptor p55, p75 and CA-125 measured prospectively and preoperatively.
Result
Mean concentrations of TNFα receptor p55, p75 and CA-125 in patients with ovarian cancer were higher than in controls. The ratios of p55 and p75 receptor in ovarian cancer and controls were 0.73±0.38 and 0.55±0.06 respectively. The areas under ROC curve in detecting malignancy (all FIGO stages) were 0.73, 0.65, 0.88 and 0.85 for p55, p75, p55/p75 ratio and CA-125 respectively. The areas under ROC curve in detecting stage I of ovarian cancer were 0.52, 0.60, 0.84 and 0.66 for p55, p75, p55/p75 ratio and CA-125 respectively.
Conclusion
Serum TNFα p55/p75 ratio showed promising value in ovarian cancer detection.
Keywords: TNFα receptors, p55, p75, CA-125, Ovarian cancer, Tumor markers
To access this article, please choose from the options below
PII: S0020-7292(05)00024-X
doi:10.1016/j.ijgo.2004.12.015
© 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Inc. All rights reserved.
Volume 88, Issue 3 , Pages 292-298, March 2005
